These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5591872)

  • 1. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the conservative treatment of intermittent claudication].
    Brecht T; Hild R; Fux HD
    Munch Med Wochenschr; 1966 Dec; 108(48):2458-61. PubMed ID: 5340039
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of muscular dystrophy with "Laevadosin".
    Lip P; Flanagan J; Murray P
    Med J Aust; 1969 Jun; 1(26):1386. PubMed ID: 5797171
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical aspects and therapy of muscular dystrophies].
    Beckmann R
    Internist (Berl); 1972 Mar; 13(3):108-17. PubMed ID: 4553893
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity].
    Canani MB; Rea F; Capasso DA
    Boll Soc Ital Biol Sper; 1965 Aug; 41(16):901-4. PubMed ID: 5880029
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
    Radu H; Stenzel K; Migea S; Bordeianu L
    Munch Med Wochenschr; 1967 Dec; 109(51):2702-5. PubMed ID: 4873261
    [No Abstract]   [Full Text] [Related]  

  • 11. A trial of therapy by nucleosides and nucleotides in muscular dystrophy.
    THOMSON WH; GUEST KE
    J Neurol Neurosurg Psychiatry; 1963 Apr; 26(2):111-22. PubMed ID: 13981251
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status of experience and concepts concerning the therapy of progressive muscular dystrophies].
    Beckmann R
    Monatsschr Kinderheilkd (1902); 1968 Oct; 116(10):535-9. PubMed ID: 4889952
    [No Abstract]   [Full Text] [Related]  

  • 14. LAEVADOSIN FOR MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1964 Oct; 2(5417):1135-6. PubMed ID: 14198741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipoid changes in progressive muscular dystrophy].
    Schellnack K
    Beitr Orthop Traumatol; 1970 Jan; 17(1):91-5. PubMed ID: 5511214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy].
    Radu H; Stenzel K; Blücher G; Gödri I
    Neurol Psihiatr Neurochir; 1969; 14(5):435-42. PubMed ID: 5380160
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of muscular dystrophy with laevadosin.
    Das Gupta A
    J Indian Med Assoc; 1969 Oct; 53(8):390-2. PubMed ID: 5369189
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on progressive muscular dystrophy. I. Effects of adenosinetriphosphate and its related compounds on progressive muscular dystrophy.
    Nakahara M
    Arzneimittelforschung; 1965 Jun; 15(6):591-5. PubMed ID: 4223122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.